Literature DB >> 11961620

Bidirectional endoscopy in patients with fecal occult blood.

J P Velez1, W H Schwesinger, J Stauffer, H V Gaskill, G B Kazantsev, K R Sirinek, W E Strodel.   

Abstract

BACKGROUND: Current screening protocols for colorectal cancer depend primarily on fecal occult blood testing (FOBT). However, positive test results do not always indicate the presence of a colonic neoplasm.
METHODS: We reviewed the results of 100 consecutive bidirectional (upper and lower) endoscopic procedures performed to evaluate positive FOBT results. Patients were excluded if they presented with gross bleeding, a history of bowel lesions, or previous intestinal operations. There were 31 women and 69 men whose mean age was 51 years.
RESULTS: Major abnormalities were found on esophagogastroduodenoscopy (n = 24), colonoscopy (n = 13), or both studies (n = 2). Active bleeding was manifested in two patients, (Barrett's ulcer, duodenal arteriovenous malformation). Two other patients had malignancy: One had a cecal adenocarcinoma and the other a gastric adenocarcinoma. Various benign lesions also were identified in the stomach including esophagitis (n = 8), ulcers/erosions (n = 8) varices (n = 5), and arteriovenous malformations (n = 2). Colonic pathology included polyps (n = 8), arteriovenous malformations (n = 3), and rectal varices (n = 1). Diverticulosis and hemorrhoidal disease were present in 29 and 16 patients, respectively, but were not considered to be likely sources of a positive FOBT.
CONCLUSION: Positive FOBT results may indicate the presence of either upper or lower intestinal pathology, and bidirectional endoscopy is an efficient and accurate technique for the comprehensive evaluation of occult bleeding.

Entities:  

Mesh:

Year:  2001        PMID: 11961620     DOI: 10.1007/s004640080183

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  12 in total

1.  Positive occult blood and negative colonoscopy--should we perform gastroscopy?

Authors:  Mark T McLoughlin; Jennifer J Telford
Journal:  Can J Gastroenterol       Date:  2007-10       Impact factor: 3.522

2.  Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.

Authors:  Tsung-Hsien Chiang; Yi-Chia Lee; Chia-Hung Tu; Han-Mo Chiu; Ming-Shiang Wu
Journal:  CMAJ       Date:  2011-08-02       Impact factor: 8.262

3.  Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test.

Authors:  Lukejohn W Day; John P Cello; Ma Somsouk; John M Inadomi
Journal:  Indian J Gastroenterol       Date:  2011-09-23

4.  Is gastroscopy for fecal immunochemical test positive patients worthwhile?

Authors:  Jing Yu Ng; Dedrick Kok Hong Chan; Ker Kan Tan
Journal:  Int J Colorectal Dis       Date:  2016-09-30       Impact factor: 2.571

5.  Which should go first during same-day upper and lower gastrointestinal endoscopy? A randomized prospective study focusing on colonoscopy performance.

Authors:  Ja Sung Choi; Young Hoon Youn; Sang Kil Lee; Jin Yi Choi; Hee Man Kim; Yu Jin Kim; Ki Jun Han; Hyeon Geun Cho; Si Young Song; Jae Hee Cho
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

6.  Annual Fecal Occult Blood Testing can be Safely Suspended for up to 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients.

Authors:  Jennifer Liu; Steven Finkelstein; Fritz François
Journal:  Am J Gastroenterol       Date:  2015-08-04       Impact factor: 10.864

7.  A closer look at same-day bidirectional endoscopy.

Authors:  Jennifer Urquhart; Glenn Eisen; Douglas O Faigel; Nora Mattek; Jennifer Holub; David A Lieberman
Journal:  Gastrointest Endosc       Date:  2008-08-23       Impact factor: 9.427

8.  Long-fragment DNA as a potential marker for stool-based detection of colorectal cancer.

Authors:  Yibo Zhang; Yutaka Suehiro; Yoshitaro Shindo; Kouhei Sakai; Shoichi Hazama; Shingo Higaki; Isao Sakaida; Masaaki Oka; Takahiro Yamasaki
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

9.  Paired comparison of procedural sequence in same-day bidirectional endoscopy with moderate sedation and carbon dioxide insufflation: A prospective observational study.

Authors:  Jui-Hsiang Tang; Chi-Liang Cheng; Yen-Lin Kuo; Yi-Ning Tsui
Journal:  Saudi J Gastroenterol       Date:  2016 Sep-Oct       Impact factor: 2.485

10.  Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias.

Authors:  Yutaka Suehiro; Shinichi Hashimoto; Shingo Higaki; Ikuei Fujii; Chieko Suzuki; Tomomi Hoshida; Toshihiko Matsumoto; Yuko Yamaoka; Taro Takami; Isao Sakaida; Takahiro Yamasaki
Journal:  Oncotarget       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.